Publication
Title
Impact of combination antiretroviral therapy initiation on adherence to antituberculosis treatment
Author
Abstract
Background: Healthcare workers are often reluctant to start combination antiretroviral therapy (ART) in patients receiving tuberculosis (TB) treatment because of the fear of high pill burden, immune reconstitution inflammatory syndrome, and side-effects. Object: To quantify changes in adherence to tuberculosis treatment following ART initiation. Design: A prospective observational cohort study of ART-naive individuals with baseline CD4 count between 50 cells/mm(3) and 350 cells/mm(3) at start of TB treatment at a primary care clinic in Johannesburg, South Africa. Adherence to TB treatment was measured by pill count, self-report, and electronic Medication Event Monitoring System (eMEMS) before and after initiation of ART. Results: ART tended to negatively affect adherence to TB treatment, with an 8% - 10% decrease in the proportion of patients adherent according to pill count and an 18% - 22% decrease in the proportion of patients adherent according to eMEMS in the first month following ART initiation, independent of the cut-off used to define adherence (90%, 95% or 100%). Reasons for non-adherence were multifactorial, and employment was the only predictor for optimal adherence (adjusted odds ratio 4.11, 95% confidence interval 1.06-16.0). Conclusion: Adherence support in the period immediately following ART initiation could optimise treatment outcomes for people living with TB and HIV.
Language
English
Source (journal)
Southern African Journal of HIV Medicine
Publication
2015
ISSN
1608-9693
2078-6751
DOI
10.4102/SAJHIVMED.V16I1.346
Volume/pages
16 :1 (2015) , p. 40-45
Article Reference
346
ISI
000369119200007
Medium
E-only publicatie
Full text (Publisher's DOI)
Full text (open access)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
External links
Web of Science
Record
Identifier
Creation 15.02.2018
Last edited 29.06.2023
To cite this reference